ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Based Molecular Diagnostic Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-28P3064
Home | Market Reports | Health| Health Conditions| Cancer
Global Oncology Based Molecular Diagnostic Market Insights and Forecast to 2028
BUY CHAPTERS

Global Oncology Based Molecular Diagnostic Market Research Report 2025

Code: QYRE-Auto-28P3064
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer HealthCare
Beckton Dickinson
Cepheid Inc
Dako
Qiagen NV
Siemens
Abbott
Hologic Inc
Roche
Sysmex
Siemens Healthineers

Oncology Based Molecular Diagnostic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology Based Molecular Diagnostic Market

Oncology Based Molecular Diagnostic Market

The global market for Oncology Based Molecular Diagnostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oncology Based Molecular Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based Molecular Diagnostic.
The Oncology Based Molecular Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Based Molecular Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Based Molecular Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oncology Based Molecular Diagnostic Market Report

Report Metric Details
Report Name Oncology Based Molecular Diagnostic Market
CAGR 5%
Segment by Type
  • Instruments
  • Reagents
Segment by Application
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Kidney Cancer
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Bayer Healthcare, Beckton Dickinson, Cepheid, Dako, Hologic, Qiagen, Roche, Siemens Healthineers, Sysmex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Based Molecular Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Based Molecular Diagnostic Market report?

Ans: The main players in the Oncology Based Molecular Diagnostic Market are Abbott, Bayer Healthcare, Beckton Dickinson, Cepheid, Dako, Hologic, Qiagen, Roche, Siemens Healthineers, Sysmex

What are the Application segmentation covered in the Oncology Based Molecular Diagnostic Market report?

Ans: The Applications covered in the Oncology Based Molecular Diagnostic Market report are Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer

What are the Type segmentation covered in the Oncology Based Molecular Diagnostic Market report?

Ans: The Types covered in the Oncology Based Molecular Diagnostic Market report are Instruments, Reagents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global Oncology Based Molecular Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Liver Cancer
1.3.7 Lung Cancer
1.3.8 Blood Cancer
1.3.9 Kidney Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Molecular Diagnostic Market Perspective (2020-2031)
2.2 Global Oncology Based Molecular Diagnostic Growth Trends by Region
2.2.1 Global Oncology Based Molecular Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Based Molecular Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Oncology Based Molecular Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Oncology Based Molecular Diagnostic Market Dynamics
2.3.1 Oncology Based Molecular Diagnostic Industry Trends
2.3.2 Oncology Based Molecular Diagnostic Market Drivers
2.3.3 Oncology Based Molecular Diagnostic Market Challenges
2.3.4 Oncology Based Molecular Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue
3.1.1 Global Top Oncology Based Molecular Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Oncology Based Molecular Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Based Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Based Molecular Diagnostic Revenue
3.4 Global Oncology Based Molecular Diagnostic Market Concentration Ratio
3.4.1 Global Oncology Based Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Molecular Diagnostic Revenue in 2024
3.5 Global Key Players of Oncology Based Molecular Diagnostic Head office and Area Served
3.6 Global Key Players of Oncology Based Molecular Diagnostic, Product and Application
3.7 Global Key Players of Oncology Based Molecular Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Molecular Diagnostic Breakdown Data by Type
4.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2026-2031)
5 Oncology Based Molecular Diagnostic Breakdown Data by Application
5.1 Global Oncology Based Molecular Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Based Molecular Diagnostic Market Size (2020-2031)
6.2 North America Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Based Molecular Diagnostic Market Size by Country (2020-2025)
6.4 North America Oncology Based Molecular Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Based Molecular Diagnostic Market Size (2020-2031)
7.2 Europe Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Based Molecular Diagnostic Market Size by Country (2020-2025)
7.4 Europe Oncology Based Molecular Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Molecular Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Oncology Based Molecular Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Based Molecular Diagnostic Market Size (2020-2031)
9.2 Latin America Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Oncology Based Molecular Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Molecular Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Oncology Based Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Oncology Based Molecular Diagnostic Introduction
11.1.4 Abbott Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Introduction
11.2.4 Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.2.5 Bayer Healthcare Recent Development
11.3 Beckton Dickinson
11.3.1 Beckton Dickinson Company Details
11.3.2 Beckton Dickinson Business Overview
11.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Introduction
11.3.4 Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.3.5 Beckton Dickinson Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Details
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Oncology Based Molecular Diagnostic Introduction
11.4.4 Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.4.5 Cepheid Recent Development
11.5 Dako
11.5.1 Dako Company Details
11.5.2 Dako Business Overview
11.5.3 Dako Oncology Based Molecular Diagnostic Introduction
11.5.4 Dako Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.5.5 Dako Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Oncology Based Molecular Diagnostic Introduction
11.6.4 Hologic Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Oncology Based Molecular Diagnostic Introduction
11.7.4 Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.7.5 Qiagen Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Oncology Based Molecular Diagnostic Introduction
11.8.4 Roche Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.8.5 Roche Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Details
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Introduction
11.9.4 Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.9.5 Siemens Healthineers Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Details
11.10.2 Sysmex Business Overview
11.10.3 Sysmex Oncology Based Molecular Diagnostic Introduction
11.10.4 Sysmex Revenue in Oncology Based Molecular Diagnostic Business (2020-2025)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bayer HealthCare
Beckton Dickinson
Cepheid Inc
Dako
Qiagen NV
Siemens
Abbott
Hologic Inc
Roche
Sysmex
Siemens Healthineers
List of Tables
 Table 1. Global Oncology Based Molecular Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Instruments
 Table 3. Key Players of Reagents
 Table 4. Global Oncology Based Molecular Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Oncology Based Molecular Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Oncology Based Molecular Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Oncology Based Molecular Diagnostic Market Share by Region (2020-2025)
 Table 8. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Oncology Based Molecular Diagnostic Market Share by Region (2026-2031)
 Table 10. Oncology Based Molecular Diagnostic Market Trends
 Table 11. Oncology Based Molecular Diagnostic Market Drivers
 Table 12. Oncology Based Molecular Diagnostic Market Challenges
 Table 13. Oncology Based Molecular Diagnostic Market Restraints
 Table 14. Global Oncology Based Molecular Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Oncology Based Molecular Diagnostic Market Share by Players (2020-2025)
 Table 16. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostic as of 2024)
 Table 17. Ranking of Global Top Oncology Based Molecular Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Oncology Based Molecular Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Oncology Based Molecular Diagnostic, Headquarters and Area Served
 Table 20. Global Key Players of Oncology Based Molecular Diagnostic, Product and Application
 Table 21. Global Key Players of Oncology Based Molecular Diagnostic, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Oncology Based Molecular Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2020-2025)
 Table 25. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Oncology Based Molecular Diagnostic Revenue Market Share by Type (2026-2031)
 Table 27. Global Oncology Based Molecular Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Oncology Based Molecular Diagnostic Revenue Market Share by Application (2020-2025)
 Table 29. Global Oncology Based Molecular Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Oncology Based Molecular Diagnostic Revenue Market Share by Application (2026-2031)
 Table 31. North America Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Oncology Based Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Oncology Based Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Oncology Based Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Oncology Based Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Oncology Based Molecular Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Oncology Based Molecular Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Oncology Based Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Oncology Based Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Oncology Based Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Oncology Based Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott Oncology Based Molecular Diagnostic Product
 Table 49. Abbott Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 50. Abbott Recent Development
 Table 51. Bayer Healthcare Company Details
 Table 52. Bayer Healthcare Business Overview
 Table 53. Bayer Healthcare Oncology Based Molecular Diagnostic Product
 Table 54. Bayer Healthcare Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 55. Bayer Healthcare Recent Development
 Table 56. Beckton Dickinson Company Details
 Table 57. Beckton Dickinson Business Overview
 Table 58. Beckton Dickinson Oncology Based Molecular Diagnostic Product
 Table 59. Beckton Dickinson Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 60. Beckton Dickinson Recent Development
 Table 61. Cepheid Company Details
 Table 62. Cepheid Business Overview
 Table 63. Cepheid Oncology Based Molecular Diagnostic Product
 Table 64. Cepheid Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 65. Cepheid Recent Development
 Table 66. Dako Company Details
 Table 67. Dako Business Overview
 Table 68. Dako Oncology Based Molecular Diagnostic Product
 Table 69. Dako Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 70. Dako Recent Development
 Table 71. Hologic Company Details
 Table 72. Hologic Business Overview
 Table 73. Hologic Oncology Based Molecular Diagnostic Product
 Table 74. Hologic Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 75. Hologic Recent Development
 Table 76. Qiagen Company Details
 Table 77. Qiagen Business Overview
 Table 78. Qiagen Oncology Based Molecular Diagnostic Product
 Table 79. Qiagen Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 80. Qiagen Recent Development
 Table 81. Roche Company Details
 Table 82. Roche Business Overview
 Table 83. Roche Oncology Based Molecular Diagnostic Product
 Table 84. Roche Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 85. Roche Recent Development
 Table 86. Siemens Healthineers Company Details
 Table 87. Siemens Healthineers Business Overview
 Table 88. Siemens Healthineers Oncology Based Molecular Diagnostic Product
 Table 89. Siemens Healthineers Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 90. Siemens Healthineers Recent Development
 Table 91. Sysmex Company Details
 Table 92. Sysmex Business Overview
 Table 93. Sysmex Oncology Based Molecular Diagnostic Product
 Table 94. Sysmex Revenue in Oncology Based Molecular Diagnostic Business (2020-2025) & (US$ Million)
 Table 95. Sysmex Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Oncology Based Molecular Diagnostic Picture
 Figure 2. Global Oncology Based Molecular Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncology Based Molecular Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Instruments Features
 Figure 5. Reagents Features
 Figure 6. Global Oncology Based Molecular Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oncology Based Molecular Diagnostic Market Share by Application: 2024 VS 2031
 Figure 8. Breast Cancer Case Studies
 Figure 9. Prostate Cancer Case Studies
 Figure 10. Colorectal Cancer Case Studies
 Figure 11. Cervical Cancer Case Studies
 Figure 12. Liver Cancer Case Studies
 Figure 13. Lung Cancer Case Studies
 Figure 14. Blood Cancer Case Studies
 Figure 15. Kidney Cancer Case Studies
 Figure 16. Oncology Based Molecular Diagnostic Report Years Considered
 Figure 17. Global Oncology Based Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Oncology Based Molecular Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Oncology Based Molecular Diagnostic Market Share by Region: 2024 VS 2031
 Figure 20. Global Oncology Based Molecular Diagnostic Market Share by Players in 2024
 Figure 21. Global Top Oncology Based Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Molecular Diagnostic as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2024
 Figure 23. North America Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Oncology Based Molecular Diagnostic Market Share by Country (2020-2031)
 Figure 25. United States Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Oncology Based Molecular Diagnostic Market Share by Country (2020-2031)
 Figure 29. Germany Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Oncology Based Molecular Diagnostic Market Share by Region (2020-2031)
 Figure 37. China Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Oncology Based Molecular Diagnostic Market Share by Country (2020-2031)
 Figure 45. Mexico Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Oncology Based Molecular Diagnostic Market Share by Country (2020-2031)
 Figure 49. Turkey Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Oncology Based Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Abbott Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 53. Bayer Healthcare Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 54. Beckton Dickinson Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 55. Cepheid Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 56. Dako Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 57. Hologic Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 58. Qiagen Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 59. Roche Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 60. Siemens Healthineers Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 61. Sysmex Revenue Growth Rate in Oncology Based Molecular Diagnostic Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostics Tests Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PCR Molecular Diagnostics Market Research Report 2024
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Diagnostics Service Market Research Report 2025
Global At home Molecular Health Diagnostics Market Research Report 2025
Generic Oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Based Molecular Diagnostics Market Insights Forecast to 2030
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mobile Molecular Diagnostic System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Cancer Diagnosis Market Research Report 2024
Next Generation Breast Cancer Diagnostic and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Small Molecule Cancer Drug Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions